# Evaluator Pass

Skeptical second read of the run. Not the same voice as `evaluation.md`; this pass is deliberately adversarial.

## Things the run is quietly claiming that deserve scrutiny

### 1. That the safety landing page is better than a homepage for this product
The run chose Candidate B over a homepage and gave reasons. But those reasons rest on a search-intent assumption — that most visitors arrive via "is vegan dog food safe" queries rather than brand discovery. This is not confirmed by data. It is a plausible hypothesis. The run should state this more explicitly: the first-page decision is a testable bet, not an established fact, and the prior homepage runs are not invalidated by it.

**Implication:** First-page decisions made without traffic data should be labeled as hypotheses in the working log, not just as reasoned conclusions.

### 2. That the claim-check "caught" things the draft got wrong
The claim-check found 7 flags, all of which were resolved in the corrected draft. This is presented as the system working. But 6 of the 7 flags were scope-creep, editorial voice, or unsourced modifiers — all patterns that the anti-slop rules and drafting constraints were supposed to prevent before they reached claim-check. If the page-argument-shape step's drafting constraints are doing their job, claim-check should not be catching editorial voice. That it did suggests the drafting step did not fully internalize the constraints. This is not a failure of the run — but it is worth noting that claim-check is currently doing work that upstream constraints should have handled.

**Implication:** The page-argument-shape drafting constraints should be more explicit about the claim-scope rules, not just the slop rules. A "scope and precision" constraint block alongside the anti-slop block would reduce claim-check load on future runs.

### 3. That the corrected draft is publication-ready pending testimonials
The evaluation says "ready for publication once testimonials are available." This understates the gap. The corrected draft has no social proof at all. Section 5 (allergy path) is thin. The DACVN review scope is underspecified. These are not minor gaps — for a health-adjacent product in a skeptic-heavy category, the trust load is high and the current draft is carrying it on facts alone, with no owner stories. "Ready for publication" should be qualified more heavily.

**Implication:** Evaluation.md should have a publication readiness checklist that names what is missing, not just a general recommendation.

## Punch list for repo improvement

1. **First-page decision template** — add a field: "Confidence basis for this decision (data, signal, hypothesis)." Forces runs to label how well-grounded the first-page choice is.
2. **Page-argument-shape drafting constraints** — add a "scope and precision" block alongside the anti-slop block, covering: no external-credential scope beyond what briefs support, no unsourced quantitative modifiers, no outrun mechanism claims. Currently these are in the claim-check framework but not in the shape step where they should be caught earlier.
3. **Evaluation template** — add a "publication readiness checklist" field that names what is still missing before the page can publish. The current template has "what stayed thin" but no explicit gap-to-publication mapping.

## Final evaluator read

The run is real in the sense that matters: it produced a page that no prior run in this repo produced, grounded in concrete product facts, and cleaned through a full claim-check. The first-page decision is the most substantive contribution — the safety landing page structure is genuinely different from either prior homepage, and the argument for it is coherent even if unproven by traffic data. The run's main weakness is that it is honest about what it has (AAFCO, grain-inclusive, DACVN review, guarantee) but has not yet done the work of acknowledging how thin that base is for a category where social proof and vet endorsement are major purchase drivers. The corrected draft is clean and honest; it is also, by itself, unlikely to convert a genuinely skeptical owner without the testimonials and further DACVN-scope detail that are currently missing.
